Citation Impact
Citing Papers
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
2002
Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
2015
Breast cancer
2019 Standout
The role of the insulin-like growth factor-1 system in breast cancer
2015
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
2002
Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study
2003
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2
2002
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
Periodontal microbial ecology
2005 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Acromegaly
2006 Standout
Professional opportunities and responsibilities in the provision of genetic information to children relinquished for adoption
2003
Growth Hormone Treatment of Non–Growth Hormone-Deficient Growth Disorders
2007
Cancers Associated with Acromegaly
2006
The insulin-like growth factor system in advanced breast cancer
2003
Effects of caffeine on human health
2003 Standout
Mammalian phytoestrogens: enterodiol and enterolactone
2002
An integrative model of shared decision making in medical encounters
2005 Standout
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
2001
Breast cancer cell response to genistein is conditioned by BRCA1 mutations
2009
Insulin and related factors in premenopausal breast cancer risk
1998
The GH–IGF-I axis and breast cancer
2003
Patient Centered Experiences in Breast Cancer
2007
International table of glycemic index and glycemic load values: 2002,
2002 Standout
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group
2006
Acromegaly: Re-thinking the cancer risk
2007
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
1998
Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial
2001
Growth Hormone Receptor Antagonists
2004
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
1999
Plasma Insulin-Like Growth Factor-I and Serum IGF-Binding Protein 3 Can Be Associated with the Progression of Breast Cancer, and Predict the Risk of Recurrence and the Probability of Survival in African-American and Hispanic Women
1999
An update on bioactive plant lignans
2005 Standout
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
2001
Serum concentrations of IGF‐I, IGFBP‐3 and c‐peptide and risk of hyperplasia and cancer of the breast in postmenopausal women
2003
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Communicating sad, bad, and difficult news in medicine
2004 Standout
Dietary phenolics: chemistry, bioavailability and effects on health
2009 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Eliciting patients’ preferences for adjuvant chemotherapy in breast cancer: development and validation of a bedside decision‐making instrument in a French Regional Cancer Centre
2000
Genetic Testing for Prostate Cancer
2000
Glutathione Metabolism and Its Implications for Health
2004 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Primary surgery for ovarian cancer
2006
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer
1999
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Effect of glutamine on glutathione, IGF-I, and TGF-β1
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients
2006
Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden
2002
Suppression of mammary gland tumorigenesis in diabetic rats
2003
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study
2001
Patients' Preferences for Participation in Clinical Decision Making: A Review of Published Surveys
1998
Energy Balance, Physical Activity, and Cancer Risk
2008
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
2010 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside
2000
Shared decision‐making in question
2001
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
2001
Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
2008 Standout
Immunological Functions of the Omentum
2017 Standout
The Growing Problem of Obesity in Dogs and Cats
2006 Standout
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Coffee and Health: A Review of Recent Human Research
2006 Standout
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
The omentum and omentectomy in epithelial ovarian cancer: A reappraisal
2013
Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer
2003
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis
2001
Serum insulin-like growth factor-I and breast cancer
2000
Obesity and cancer
2004
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
2007
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Inherited Medullary Thyroid Cancer and the Duty to Warn: Revisiting Pate v. Threlkel in Light of HIPAA
2005
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Oncologists’ Attitudes Toward and Practices in Giving Bad News: An Exploratory Study
2002
Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview
2001
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
2002
The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer
2005
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
2010
Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening among African American men
2013
2015
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Diabetes and Cancer
2010 Standout
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
2000
Patients’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests
2014
Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
2003
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density
2005
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Disrupting insulin-like growth factor signaling as a potential cancer therapy
2007
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
2001
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Effects of a Decision Support Intervention on Decisional Conflict Associated with Microsatellite Instability Testing
2011
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
2000
SPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer
2000 Standout
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
2005 Standout
Works of Philippe Vennin being referenced
Cancer du sein : l'information en question(s). Enquête auprès des patientes et des médecins d'un Centre de lutte contre le cancer
1995
Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
1993
Novel indications forBRCA1 screening using individual clinical and morphological features
1999
Tamoxifen Adjuvant Treatment Duration in Early Breast Cancer: Initial Results of a Randomized Study Comparing Short-Term Treatment With Long-Term Treatment
2000
Surgical staging of early invasive epithelial ovarian tumors
2000
Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors
2000
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG–PET after the first course
2011
Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern France
1998
Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development
2011
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
2006
[Breast neoplasms: information in question(s). A survey of patients and physicians at a cancer treatment center].
1995
Attitudes towards cancer predictive testing and transmission of information to the family.
1996
What do gastroenterologists, surgeons and oncologists tell patients with colon cancer ? results of a survey from the northern france area
1998